ORPHA:85410
Oligoarticular juvenile idiopathic arthritis
Also known as: Oligoarticular JIA · Pauciarticular chronic arthritis
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
3,392
90.7th percentile
Trials
1
Interventional, condition-specific
Researchers
1,284
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare inflammatory rheumatic disease characterized by juvenile onset arthritis that affects fewer than 5 joints during the first 6 months after disease onset.
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019433
- MeSH:C536312
- UMLS:C2931171
- NCIT:C119032
Additional Mondo synonyms (2)
Pauciarticular JIA · Pauciarticular juvenile idiopathic arthritis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,392 matched papers (2,160 in last 10 years) Source
- Phenotype characterisedPresent
20 HPO annotations (e.g. Oligoarthritis; Abnormality of the ankle; Band keratopathy) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
1 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
20
Associated phenotypes · MONDO:0019433
- Oligoarthritis
- Abnormality of the ankle
- Band keratopathy
- Reduced visual acuity
- Cataract
Showing 5 of 20 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
2 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Naproxen · therapeutic
- Tolmetin · therapeutic
Literature
Is anyone studying this?
3,392
3,392 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,392 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2,160 in the last 10 years · high confidence · 90.7th percentile (publications denominator)
Phrase hits: 3,392 · MeSH hits: 0
Who's working on it?
1,284
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Kahn R9 papers · 2026
Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Papers in Europe PMC - 02Mossberg A9 papers · 2026
Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Papers in Europe PMC - 03Schmidt T9 papers · 2026
Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Papers in Europe PMC - 04Berthold E8 papers · 2024
Department of Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden.
Papers in Europe PMC - 05Bilginer Y8 papers · 2025
Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University, Ankara, Türkiye.
Papers in Europe PMC - 06Kahn F8 papers · 2026
Department of Infection Medicine, Clinical Sciences Lund, Lund University, Lund, Sweden.
Papers in Europe PMC - 07Arve-Butler S7 papers · 2023
Department of Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden.
Papers in Europe PMC - 08Bengtsson AA7 papers · 2026
Department of Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden.
Papers in Europe PMC - 09Karagöl C7 papers · 2025
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital, Bilkent, 06800, Ankara, Turkey.
Papers in Europe PMC - 10Batu ED6 papers · 2025
Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University, Ankara, Türkiye.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting. 175 trials are registered for juvenile idiopathic arthritis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).
high confidence · 80.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Broader category: juvenile idiopathic arthritis
175
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07184450·RECRUITING·Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Not reviewed·Conditions: Juvenile Dermatomyositis (JDM) · Polyarticular Juvenile Idiopathic Arthritis · Systemic Sclerosis (SSc) · Primary Sjogren's Syndrome·Matched via name phrase
- NCT07386587·ENROLLING BY INVITATION·Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT05984758·NOT YET RECRUITING·Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Uveitis, Anterior · Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT02991469·RECRUITING·A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06376149·RECRUITING·M3-JIA: Making Mindfulness Matter for Children With JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis · Children · Mental Health · Mental Well-being·Matched via name phrase
- NCT06184100·RECRUITING·Virtual Self-Management Program for JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07553182·RECRUITING·OLE Study With Filgotinib in JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT06888973·ENROLLING BY INVITATION·Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Not reviewed·Conditions: Rheumatoid Arthritis · Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Ankylosing Spondylitis (AS)·Matched via name phrase
- NCT07634354·NOT YET RECRUITING·Sarcopenia and Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06618937·NOT YET RECRUITING·Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07217782·RECRUITING·Pain in Juvenile Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07234747·RECRUITING·Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07661069·NOT YET RECRUITING·YOGA FOR CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07554495·RECRUITING·Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
Not reviewed·Conditions: Polyarticular Course Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07087912·RECRUITING·Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not reviewed·Conditions: Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE) · Juvenile Systemic Lupus Erythematosus·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07553910·NOT YET RECRUITING·Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis · Tenosynovitis · Polyarticular Juvenile Idiopathic Arthritis · Oligoarticular Juvenile Idiopathic Arthritis·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (2)
- isrctn·ISRCTN54174557·Recruiting·Steroid Treatment Trial in JIA (STAR-JIA): A randomised trial to compare the effectiveness, safety and cost-effectiveness of intravenous versus oral corticosteroid induction regimens for children and young people with juvenile idiopathic arthritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95363507·No longer recruiting·Tocilizumab in anti-TNF refractory patients with juvenile idiopathic arthritis (JIA) associated uveitis
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Oligoarticular juvenile idiopathic arthritis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Oligoarticular juvenile idiopathic arthritis" OR "Oligoarticular JIA" OR "Pauciarticular chronic arthritis" OR "Pauciarticular JIA" OR "Pauciarticular juvenile idiopathic arthritis"
MeSH descriptor terms unioned into the query: Juvenile pauciarticular chronic arthritis
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Oligoarticular juvenile idiopathic arthritis" OR "Oligoarticular JIA" OR "Pauciarticular chronic arthritis" OR "Pauciarticular JIA" OR "Pauciarticular juvenile idiopathic arthritis" OR "Juvenile pauciarticular chronic arthritis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"juvenile idiopathic arthritis"
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T02:59:54.189Z
